- Diagnostic Différentiel
Drug Information for Simulect (Novartis Pharmaceuticals Corporation): WARNING
- CLINICAL STUDIES
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to Simulect (Novartis Pharmaceuticals Corporation)
- Liens externes liés à Simulect (Novartis Pharmaceuticals Corporation)
Only physicians experienced in immunosuppression therapy and management of organ transplantation patients should prescribe Simulect® (basiliximab). The physician responsible for Simulectadministration should have complete information requisite for the follow-up of the patient. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources.
- Drug Information Provided by National Library of Medicine (NLM).